" class="no-js "lang="en-US"> Bill & Melinda Gates Foundation Archives - Medtech Alert
Saturday, April 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease | MTA

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Read more

Diseases

 Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases | MTA

Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases

Aegis Life and its parent company Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines […]

Fundraising

 Nanoform Receives Funding to Solve Challenges for Global Health | Pharmtech Focus

Nanoform Receives Funding to Solve Challenges for Global Health

Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be […]

Artificial Intelligence

 Exscientia Accelerates COVID-19 Drug Discovery Using AI | Pharmtech Focus

Exscientia Accelerates COVID-19 Drug Discovery Using AI

Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy […]

COVID-19

 The Bill & Melinda Gates Foundation Pledges $50 Million to Increase Access to Safe and Affordable COVID-19 Vaccines in Lower-income Countries | Pharmtech Focus

The Bill & Melinda Gates Foundation Pledges $50 Million to Increase Access to Safe and Affordable COVID-19 Vaccines in Lower-income Countries

The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the […]

COVID-19

 Statement from Gates Foundation CEO Mark Suzman: No Barriers Should Stand in the Way of Equitable Vaccines Access | Pharmtech Focus

Statement from Gates Foundation CEO Mark Suzman

The Bill & Melinda Gates Foundation has been working urgently since January 2020 with a […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more